In accordance with Moorfields Eye Hospital, a hospital for vision problems in London, one The British became the first patient in the world to have a prosthetic eye, created by a 3D printing process.
The patient is called Steve Verze, is 47 years old, hails from Hackney and works as an engineer. The Briton acquired the 3D-printed eye (left eye) yesterday, after a size test was performed earlier in the month.
Moorfields Eye Hospital said in a press release that the 3D prosthetic eye is the first fully digital prosthetic eye created for a patient.
The eye is more realistic than other alternatives and is designed to offer “more precise definition and real depth to the daughter", Said the hospital.
In addition, the process is considered less invasive.
The placement of traditional prosthetic eyes requires the taking of a mold from the eye socket, while in prosthetic eyes that use the 3D-printing technology, the niche is scanned digitally to create a detailed image.
Mr Verze's functional eye was also scanned to ensure that both eyes would look the same.
The XNUMXD image was then sent to Germany for printing, before being sent back to the United Kingdom, where it was completed by an ophthalmologist at Moorfields Eye Hospital.
"I needed a prosthetic eye from my 20s", Mr. Verze reportedly said in the press release.
"When I leave my house I often take a second look in the mirror and I did not like what I saw. This new eye looks fantastic and, thanks to 3D digital printing technology, will get better and better".
Moorfields Eye Hospital also said that 3D printing also significantly reduces the time it takes for a prosthetic eye to develop (from six weeks to about two or three).
A spokesman told CNN that a clinical trial with more patients would begin soon.
Professor Mandeep Sagoo, project manager at Moorfields Eye Hospital and professor of ophthalmology at University College London, said he was "excited" about the potential of the new method.
Speaking before the eye was placed, Professor Sagoo said: “We hope that the forthcoming clinical trial will provide us with strong insights into the value of this new technology.".